Patent Yard Sign in
Canadian application, no grantCanada

3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators

CA 2409430 A1 · Owner: Gao, Ping · Inventors: Gao, Ping; Koenig, Marcel; Morozowich, Walter

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention is directed to prodrugs of certain 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives that modulate the activity of protein kinases ("PKs"). Pharmaceutical compositions comprising these compounds methods of treating diseases related to abnormal PK activity utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 24, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 24, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 24, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 24, 2001
GrantedNo grant recorded
Term endedMay 24, 2021
Patent numberCA 2409430 A1
Classification (IPC)C07D403/06 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedMay 24, 2001Term endedMay 24, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.